Nasal distribution of budesonide inhaled via a powder inhaler.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Rhinology

• Publication date

  1993-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 8321983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• A current update on advanced drug delivery devices for nasal and pulmonary administration

  2021cites this paper
• Nasal Powder Formulation of Tranexamic Acid and Hyaluronic Acid for the Treatment of Epistaxis

  2020cites this paper
• Inhalation and Nasal Formulations

  2016cites this paper
• Medicinski proizvodi namijenjeni nazalnoj primjeni lijekova

  2016cites this paper
• Intranasal Deposition of Accuspray™ Aerosol in Anatomically Correct Models of 2-, 5-, and 12-Year-Old Children

  2015cites this paper
• Experimental Measurements and Computational Predictions of Regional Particle Deposition in a Sectional Nasal Model

  2015cites this paper
• Influence of Dosage Form, Formulation, and Delivery Device on Olfactory Deposition and Clearance: Enhancement of Nose-to-CNS Uptake

  2015cites this paper
• Mechanisms of Pharmaceutical Aerosol Deposition in the Respiratory Tract

  2014cites this paper
• Measurement of Drug in Small Particles from Aqueous Nasal Sprays by Andersen Cascade Impactor

  2012cites this paper
• Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review

  2012cites this paper
• Nasal Deposition and Clearance in Man: Comparison of a Bidirectional Powder Device and a Traditional Liquid Spray Pump

  2012cites this paper
• How the Lung Handles Drugs

  2012cites this paper
• Effective treatment of mild-to-moderate nasal polyposis with fluticasone delivered by a novel device.

  2009cites this paper
• A new method for scintigraphic quantification of deposition and clearance in anatomical regions of the human nose

  2009cites this paper
• DirectHalerTM Nasal: Innovative Device and Delivery Method

  2008cites this paper
• Numerical Simulations Investigating the Regional and Overall Deposition Efficiency of the Human Nasal Cavity

  2008cites this paper
• Devices for Aerosol Delivery to Treat Sinusitis

  2007cites this paper
• Nose-to-brain delivery of TS-002, prostaglandin D2 analogue

  2007cites this paper
• Characterization of Deposition from Nasal Spray Devices Using A Computational Fluid Dynamics Model of The Human Nasal Passages

  2007cites this paper
• Breath Actuated Device Improves Delivery to Target Sites Beyond the Nasal Valve

  2006cites this paper
• Topical glucocorticosteroids in rhinitis: clinical aspects

  2006cites this paper
• Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation.

  2006cites this paper
• Radionuclide imaging studies in the assessment of nasal drug delivery in humans

  2004cites this paper
• Drug delivery to the nasal cavity: in vitro and in vivo assessment.

  2004cites this paper
• How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids.

  2004cites this paper
• Bi-Directional Nasal Delivery of Aerosols Can Prevent Lung Deposition

  2004cites this paper
• Gamma scintigraphy in the evaluation of pharmaceutical dosage forms

  2004cites this paper
• Particle Deposition in Human Nasal Airway Replicas Manufactured by Different Methods. Part I: Inertial Regime Particles

  2004cites this paper
• The impact of expiration on particle deposition within the nasal cavity.

  2003cites this paper
• Modeling Aerosol Drug Delivery

  2003cites this paper
• Safety and Tolerability Profiles of Intranasal Antihistamines and Intranasal Corticosteroids in the Treatment of Allergic Rhinitis

  2003cites this paper
• Nasal Drug Delivery

  2003cites this paper
• Deposition and pharmacokinetics of budesonide from the Miat Monodose inhaler, a simple dry powder device.

  2002cites this paper
• Lung deposition of budesonide from the novel dry powder inhaler AirmaxTM

  2002cites this paper
• Gamma Scintigraphic Evaluation of a Novel Budesonide Dry Powder Inhaler Using a Validated Radiolabeling Technique

  2002influential citation
• Lung deposition of budesonide from the novel dry powder inhaler Airmax.

  2002cites this paper
• Comparison of once daily fluticasone propionate aqueous nasal spray with once daily budesonide reservoir powder device in patients with perennial rhinitis

  2001cites this paper
• A comparison of the lung deposition of budesonide from Easyhaler, Turbuhaler and pMDI plus spacer in asthmatic patients.

  2001cites this paper
• Characterization of Nasal Spray Pumps and Deposition Pattern in a Replica of the Human Nasal Airway

  2001cites this paper
• Nasal peak inspiratory flow through Turbuhaler® in children with symptomatic rhinitis and in healthy children

  2000cites this paper
• Systemic activity versus systemic adverse effects of nasal glucocorticoids in the treatment of allergic rhinitis

  2000cites this paper
• Scintigraphic comparison of budesonide deposition from two dry powder inhalers.

  2000cites this paper
• Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder.

  1999cites this paper
• Lung deposition of budesonide in asthmatics: a comparison of different formulations

  1998cites this paper
• Nasal delivery systems and their effect on deposition and absorption.

  1998cites this paper
• Topical Corticosteroid Therapy of Rhinitis

  1996cites this paper
• Einsatz moderner Bilddatenverarbeitung in der klinisch-rhinologischen Forschung

  1996cites this paper
• Scintigraphic Assessment of the Oropharyngeal and Nasal Depositions of Fusafungine from a Pressurized Inhaler and from a Novel Pump Spray Device

  1995cites this paper
• Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects.

  1994cites this paper
• Studies using radiolabelled aerosols in children.

  1994cites this paper
• Nasal powder administration of bud for seasonal rhinitis in children and adolescents

  1993cites this paper
• Glucocorticosteroids and rhinitis

  1993cites this paper
• Occasional review Studies using radiolabelled aerosols in children

  year unknowncites this paper